David D. Allison - Jan 6, 2022 Form 3 Insider Report for CinCor Pharma, Inc. (CINC)

Role
Director
Signature
/s/ Cathy Rude, Attorney-in-Fact
Stock symbol
CINC
Transactions as of
Jan 6, 2022
Transactions value $
$0
Form type
3
Date filed
1/6/2022, 07:51 PM
Previous filing
Jul 13, 2021
Next filing
Jul 20, 2022

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding CINC Stock Option (Right to Buy) Jan 6, 2022 Common Stock 29.4K $13.60 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This option vests in equal annual installments over a three-year period measured from one year following December 10, 2021, subject to the continued service by the Reporting Person to the Issuer as of the applicable vesting date.

Remarks:

Exhibit List - Exhibit 24 - Power of Attorney